← All comparisons
Head-to-head · FAERS comparison

Spironolactone vs Finasteride: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

SpironolactoneFinasteride
Drug classAldosterone Antagonist5-alpha Reductase Inhibitor
Brand names––
FAERS reports139,59959,947
Serious78%65%
Death outcome18,0665,092
Boxed warningNoNo

Signals both drugs share

No strong shared signal after removing coding and lab terms.

Labeled signals distinctive to Spironolactone

Labeled signals distinctive to Finasteride

Common questions

Which has more reported side effects, Spironolactone or Finasteride?

Spironolactone has 139,599 FAERS reports and Finasteride 59,947. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (78% vs 65%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Spironolactone and Finasteride share?

They share no strong flagged signal after artifacts and lab terms are removed.

Is Spironolactone or Finasteride safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.